Navigation Links
TRPM8 in Medical News
Role of Protein in the Development of Prostate Cancer Identified
...t studies have indicated that the protein known as trpm8 plays an important role in prostate cancer: high levels of trpm8 have been found in prostate carcinoma compared to normal prostate epithelial cells, and trpm8 has been suggested as a specific marker and therap...Detecting Cold, Feeling Pain: Study Reveals Why Menthol Fresh
...tes how the body experiences intense stimuli temperature, in this case that can cause pain. As such, the receptor known as menthol receptor trpm8 -- provides a target for studying acute and chronic pain, as can result from inflammatory or nerve injury, the researchers say, and a potential new ta...Menthol Receptor-A Thermosensitivity Determinant in Cold Temperature
...olves the mystery of how important the ion channel trpm8 is for alerting the body to cold temperatures.TRPM...d that isolated, cultured nerve cells that express trpm8 react to cooling stimuli, but cells cultured from mice lacking trpm8 do not. Also, mice engineered without...Chronic pain can be cooled off !
...nt in the skin, which effectively transmits the cooling sensation. The scientists remarked: 'We have found that if you can selectively activate the trpm8 receptor, then you have a chance of suppressing other sensory inputs coming into the nervous system that are carrying pain information. We found a ver...TRPM8 in Medical Technology
-- Data Presented at American Urological Association Annual Meeting --
SEATTLE and CHICAGO, April 28 /PRNewswire-FirstCall/ -- Researchers from Dendreon Corporation (Nasdaq: DNDN ) today presented preclinical data demonstrating the potential of D-3263, Dendreon's orally bioavailable small m...
...immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...
...mmunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington...
Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
SEATTLE, April 21 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) today announced that the Company has enrolled the first patient in a Phase 1 clinical trial of D3263 in patients with advanced cancer. D3263 is Dendreon's lead small molecule drug candidate designed to target TRPM8......immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...
...mmunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington...
TRPM8 in Biological News
Detecting cold, feeling pain: Study reveals why menthol feels fresh
...es how the body experiences intense stimuli – temperature, in this case – that can cause pain. As such, the receptor – known as menthol receptor trpm8 -- provides a target for studying acute and chronic pain, as can result from inflammatory or nerve injury, the researchers say, and a potential new ta...Scripps research team sheds light on long-sought cold sensation gene
...ve withstood the test of genetics," he says. trpm8 was first discovered by Patapoutian’s group and pr...ould choose between two temperatures, mice without trpm8 showed essentially no preference in the temperatur...normal mice to flick their paw and lick them. trpm8 codes for an ion channel found at the tips of sens...Novel method reveals how menthol discovery could point towards new or improved pain therapies
...utagenesis and high-throughput screening approach, the study assayed 14,000 trpm8 mutants to find mutants that were not enhanced by menthol but were otherwis...ur experiments yielded significant insights into the functional elements of trpm8 ion channel protein that would have been difficult to obtain using other mu...TRPM8 in Biological Technology
Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET
...mmunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
...mmunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ......immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...
Dendreon Announces Closing of Common Stock Offering
...mmunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington...Dendreon Announces Common Stock Offering
...immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
...mmunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...Dendreon Reports First Quarter 2009 Financial Results
... announcing that D3263, a small molecule targeting trpm8 (a transmembrane cation channel protein), reduced ...acokinetics of orally-administered D3263 targeting trpm8 in patients with solid tumors that are refractory ...ng an orally-available small molecule that targets trpm8 that could be applicable to multiple types of canc...Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting
...:30 a.m. to 12:30 p.m. CDT - Abstract #1408: "Preclinical Evaluation of the trpm8 Ion Channel Agonist D-3263 for Benign Prostatic Hyperplasia." Poster prese...Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign pros......immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...
...immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets trpm8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington ...
TRPM8 in Biological Products
Rabbit Anti-TRPM8 Polyclonal Antibody, Unconjugated from Abcam
Description:... Rabbit polyclonal to trpm8 (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 79054 SwissProtID: Q3YFM7...Company:Abcam
Other TagsOther Contents
astronomystymiediversionwiseBenitecTeradataanestheticslaunchingPewlaunchpadmascotbelovedminimizesMedAssets
(Date:5/20/2013)... Chicago, IL (PRWEB) May 20, 2013 ... of innovative cloud and on-premise business process ... version 6.0 of its next-generation integration solution. ... data integration solution that seamlessly automates business ... and reporting with meaningful business user interaction ...
(Date:5/20/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) -- ... out in the late 1990s is more effective than ... contends. Teenagers who received four shots with the ... were 2 years old were significantly less likely to ... in California, compared to children who received all of ...
(Date:5/20/2013)... Mich. As high schoolers prepare for final exams, ... drug" -- a prescription stimulant or amphetamine -- to ... Michigan poll shows only one in 100 parents of ... used a study drug., Study drugs refer to stimulant ... hyperactivity disorder (ADHD); commonly prescribed medicines in this category ...
(Date:5/20/2013)... 20, 2013 Medicare Part D seniors ... citing lower costs, convenient access to pharmacies and other ... Associates released today by the Pharmaceutical Care Management Association ... million) are currently enrolled in plans with preferred networks. ... overall value of plans with preferred pharmacy networks,” said ...
(Date:5/20/2013)... It’s May which means it’s Bike Month! If ... out those dusty bikes and helmets. , Windsong Production's and ... in the office with Windsong Productions challenging ... pledged miles for the 4th Annual Million Mile Challenge. They ... , *insert battle prep montage* , This is all part ...
Breaking Medicine News(10 mins):Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 2Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 3Health News:Study: Older Whooping Cough Vaccine More Effective 2Health News:Study: Older Whooping Cough Vaccine More Effective 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2Health News:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2[0] Adeptia Announces New Release of Enterprise Business Integration Solution[0] Study: Older Whooping Cough Vaccine More Effective[0] 1 in 10 teens using 'study drugs,' but parents aren't paying attention[0] Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices[0] I Bike Fresno's 4th Annual Million Mile Challenge
(Date:5/16/2013)... May 16, 2013 Integrated Biometrics patented ... a custom thin film transistor camera introduces Sherlock, ... roll image in the smallest and lightest form ... Appendix F Mobile ID FAP 45, Certified scanner ... in size and weight when compared to optical ...
(Date:5/16/2013)... that are about 23 million years old give ... gobioid order, one of the most species-rich groups ... by paleontologist Professor Bettina Reichenbacher from the Division ... Earth and Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in ... of fish fossils which they assign to the ...
(Date:5/16/2013)... The use of genome-wide analysis (GWA), where the entirety ... the genomic mutations or variants which can cause health ... However, it can also pose major ethical problems ... Society of Human Genetics (ESHG) published on line today ... Human Genetics ., Many services based on whole genome ...
Breaking Biology News(10 mins):Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |